logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > 2,4-Dichloro-5-m ethoxyaniline CAS 98446-49-2

2,4-Dichloro-5-m ethoxyaniline CAS 98446-49-2

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 98446-49-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS No::
98446-49-2
Appearance::
Pale Brown Solid
Molecular Formula::
C7H7Cl2NO
Molecular Weight::
192.04
EINECS NO::
619-345-9
MDL NO.::
MFCD00974410
CAS No::
98446-49-2
Appearance::
Pale Brown Solid
Molecular Formula::
C7H7Cl2NO
Molecular Weight::
192.04
EINECS NO::
619-345-9
MDL NO.::
MFCD00974410
2,4-Dichloro-5-m ethoxyaniline CAS 98446-49-2

Product Description:

Product Name:2,4-Dichloro-5-m ethoxyaniline CAS 98446-49-2

 

Synonyms:

4,6-Dichloro-m-anisidine;

5-AMINO-4,6-DICHLOROANISOLE;

BENZENAMINE,2,4-DICHLORO-5-M ETHOXY-.

 

Chemical & Physical Properties

Appearance:Pale Brown Solid

Assay: NLT98%

Melting Point:51 °C

Boiling point:290.1±35.0 °C

Density:1.375±0.06 g/cm3

Solubility:Chloroform (Slightly), Methanol (Slightly)

 

Safety Information

Risk Statements:R20/21/22

Hazard Codes:Xi,Xn

HS Code:2922290090

 

Application:2,4-Dichloro-5-m ethoxyaniline is mainly used in the preparation of bosutinib intermediate 4-[(2,4-dichloro-5-m ethoxyphenyl)amino]-6-met hoxy -7-(3-Chloropropoxy)-3-quinolinecarbonitrile.Bosutinib, developed by Wyeth Pharmaceuticals of the United States, was approved by the European Union as an "orphan drug" in September 2010 for the treatment of chronic myelogenous leukemia (CML).On September 4, 2012, the drug was approved by the U.S. Food and Drug Administration (FDA) for marketing under the trade name Bosulif.It was approved for marketing by the European Food and Drug Administration (EMA) on March 27, 2013, and approved by Japan's PMDA on September 26, 2014.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.